Pierre Chabot

3.8k citations

29 papers · 2.4k indexed · 2 hit papers · h-index 14

Impact in

Pulmonary and Respiratory Medicine top 1%
- Sarcoma Diagnosis and Treatment
- Brain Metastases and Treatment
Oncology top 2%
- Vascular Tumors and Angiosarcomas

Papers in

Oncology 15
- Lung Cancer Research Studies 6
- Cancer Diagnosis and Treatment 4
Pulmonary and Respiratory Medicine 16
- Brain Metastases and Treatment 7
- Sarcoma Diagnosis and Treatment 5

Co-authors: Aileen M. Davis Jay S. Wunder Rita A. Kandel Brian O’Sullivan Joseph L. Pater Charles Catton Anna Sadura Karen Goddard
Journals: Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Radiotherapy and Oncology (2 papers)Journal of Neuro-Oncology (2 papers)JAMA Oncology (1 paper)
Partner nations: Canada United States Spain

In The Last Decade

Pierre Chabot

29 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma 2005 · 503 citations

Peers

Countries citing papers authored by Pierre Chabot

Since Specialization

Citations

This map shows the geographic impact of Pierre Chabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chabot more than expected).

Fields of papers citing papers by Pierre Chabot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chabot. The network helps show where Pierre Chabot may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Chabot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Chabot Line = papers co-authored together Pierre Chabot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-World Patient- and Caregiver-reported Outcomes in Advanced Breast Cancer Current Oncology ·Tomas Mondino, Thamer M. Jamel, Choerunnissa Febriani, Giovanni Zanotti, A. Trémier, Mihaela Mates, Julie Lemieux, Pierre Chabot, Catherine Prady, Félix Couture, Jean Lachaîne	2018	13
2	Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial Annals of Palliative Medicine ·Selina Chow, Keyue Ding, Bo Wan, Michael Brundage, Ralph M. Meyer, Abdenour Nabid, Pierre Chabot, Geneviève Coulombe, Shahida Ahmed, Joda Kuk, A. Rashid Dar, Aamer Mahmud, Alysa Fairchild, Carolyn F. Wilson, Jackson Wu, Kristopher Dennis, Carlo DeAngelis, Rebecca Wong, Liting Zhu, Edward Kai‐Hua Chow	2017	11
3	A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy Radiotherapy and Oncology ·Srinivas Raman, Keyue Ding, Edward Chow, Ralph M. Meyer, Abdenour Nabid, Pierre Chabot, Geneviève Coulombe, Shahida Ahmed, Joda Kuk, A. Rashid Dar, Aamer Mahmud, Alysa Fairchild, Carolyn F. Wilson, Jackson Wu, Kristopher Dennis, Carlo DeAngelis, Rebecca Wong, Liting Zhu, Michael Brundage	2016	15
4	A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers Value in Health ·Tomas Mondino, Hande BULDUK, Choerunnissa Febriani, Giovanni Zanotti, Ritesh Banerjee, Mihaela Mates, Julie Lemieux, Pierre Chabot, Catherine Prady, Félix Couture, Jean Lachaîne	2016	2
5	Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22 Supportive Care in Cancer ·Rachel McDonald, Keyue Ding, Edward Chow, Ralph M. Meyer, Abdenour Nabid, Pierre Chabot, Geneviève Coulombe, Shahida Ahmed, Joda Kuk, Dominica Sherly Novita Widayanti, Aamer Mahmud, Alysa Fairchild, Carolyn F. Wilson, Jackson Wu, Kristopher Dennis, Carlo DeAngelis, Rebecca Wong, Liting Zhu, Michael Brundage	2016	4
6	Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy Quality of Life Research ·Srinivas Raman, Keyue Ding, Edward Chow, Ralph M. Meyer, Abdenour Nabid, Pierre Chabot, Geneviève Coulombe, Shahida Ahmed, Joda Kuk, A. Rashid Dar, Aamer Mahmud, Alysa Fairchild, Carolyn F. Wilson, Jackson Wu, Kristopher Dennis, Carlo DeAngelis, Rebecca Wong, Liting Zhu, Michael Brundage	2016	18
7	Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study Journal of Neuro-Oncology ·Pierre Chabot, Te‐Chun Hsia, Jeong‐Seon Ryu, В. А. Горбунова, Cristóbal Belda-Iniesta, David Ball, Ebenezer A. Kio, Minesh P. Mehta, Md. Noorunnabi Talukder, Qin Qin, Jane Qian, Kyle D. Holen, Alessandra Torres-Alcantara, John H. Suh	2016	73
8	Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial The Lancet Oncology ·Edward Chow, Ralph M. Meyer, Keyue Ding, Abdenour Nabid, Pierre Chabot, Philip Wong, Shahida Ahmed, Joda Kuk, A. Rashid Dar, Aamer Mahmud, Alysa Fairchild, Carolyn F. Wilson, Jackson Wu, Kristopher Dennis, Michael Brundage, Carlo DeAngelis, Rebecca Wong	2015	90
9	Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25 JNCI Journal of the National Cancer Institute ·Patrick Cheung, Sergio Faria, Shahida Ahmed, Pierre Chabot, Jonathan Greenland, Elizabeth Kurien, Islam Mohamed, James R. Wright, Heiner Sandmeier, Catherine de Metz, Holly R. Campbell, Nayara Carolyne Rodrigues Ribeiro, José Lucena Llamas, Elaine S. Wai, Yee Ung, Greg G. Goss, Frances A. Shepherd, Patti O’Brien, Keyue Ding, Chris J. O’Callaghan	2014	57
10	A Phase II Study of Accelerated Hypofractionated 3-dimensional Conformal Radiation Therapy for Inoperable T1-3 N0 M0 Non-small Cell Lung Cancer: NCIC CTG BR.25 International Journal of Radiation OncologyBiologyPhysics ·Chen Yi-zhuang, مینا ربانی, Р Р Гумерова, Pierre Chabot, Jonathan Greenland, Elizabeth Kurien, I. Mohamed, James R. Wright, Celes Tisdale, Chris J. O’Callaghan	2012	3
11	Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial International Journal of Radiation OncologyBiologyPhysics ·Minesh P. Mehta, William R. Shapiro, See Phan, Radj Gervais, C. Carrié, Pierre Chabot, Roy A. Patchell, Michael Glantz, Lawrence D. Recht, Corey J. Langer, Ranjan Sur, Wilson Roa, M.-A. Mahé, A. Fortin, Carsten Nieder, Christina A. Meyers, Jennifer A. Smith, Richard Miller, Markus F. Renschler	2008	124
12	PD3-1-8: Motexafin Gadolinium (MGd) is active as a single agent in advanced non-small-cell lung cancer (NSCLC) patients who failed platinum-based chemotherapy: preliminary results of a phase II trial Journal of Thoracic Oncology ·Ronald B. Natale, Garth Nicholas, Frank A. Greco, Ramaswamy Govindan, Pierre Chabot, Kishan J. Pandya, Р. Я. Садыков, Markus F. Renschler	2007	1
13	5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (SC19) Journal of Clinical Oncology ·Rebecca Wong, Nancy Paul, Keyue Ding, Marlo Whitehead, Michael Brundage, Anthony Fyles, Derek Wilke, Abdenour Nabid, A. Fortin, 正彦大久保, M. C. Gamundi Planas, Ida Ackerman, Luís Souhami, Pierre Chabot, Joseph L. Pater	2006	44
14	Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial Journal of Clinical Oncology ·Minesh P. Mehta, R. Gervais, Pierre Chabot, William R. Shapiro, Roy A. Patchell, Michael Glantz, Lawrence D. Recht, S. Phan, Jennifer A. Smith, Markus F. Renschler	2006	20
15	1110 International Journal of Radiation OncologyBiologyPhysics ·John H. Suh, Minesh P. Mehta, Anne Dagnault, Pierre Chabot, Eric L. Chang, Marie-Andrée Fortin, J.C. Grecula, Abdenour Nabid, Luís Souhami, Markus F. Renschler	2006	1
16	Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma Radiotherapy and Oncology ·Aileen M. Davis, Brian O’Sullivan, R. Turcotte, Randall Bell, C. Catton, Pierre Chabot, Jay S. Wunder, Alison Hammond, V. Benk, Rita A. Kandel Hit paper breakdown →	2005	503
17	FUNCTION AND HEALTH STATUS OUTCOMES IN A RANDOMIZED TRIAL COMPARING PRE-OPERATIVE AND POST-OPERATIVE RADIOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMA Aileen M. Davis, Brian O’Sullivan, Robert S. Bell, Robert Turcotte, C. Catton, 哲史飯尾, Pierre Chabot, A. Hammond, V. Benk, Marc Isler, Carolyn Freeman, Karen Goddard, Andrea Bezjak, Rita A. Kandel, Anna Sadura, A. Day, Víctor Jesús Huárniz Noya, Dongsheng Tu, Joseph L. Pater, Benny Zee	2004	1
18	Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial The Lancet ·Brian O’Sullivan, Aileen M. Davis, Robert Turcotte, Robert S. Bell, Charles Catton, Pierre Chabot, Jay S. Wunder, Rita A. Kandel, Karen Goddard, Anna Sadura, Joseph L. Pater, Benny Zee Hit paper breakdown →	2002	1113
19	Digital Necrosis and Lupus-Like Syndrome Preceeding Ovarian Carcinoma Dermatology ·Gudrun Thäther, F. Aubin, Laboratoire Central des Ponts et Chaussées, Pierre Chabot, R. W. Dent, Mazen Al- Body, 良輔三澤	1998	7
20	Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment International Journal of Hyperthermia ·G. P. Raaphorst, Pierre Chabot, Diina Shuuluka, David E. Wilkins, David J. Stewart, C. E. Ng	1996	15

About Pierre Chabot

Pierre Chabot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Radiation, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Management of metastatic bone disease (8 papers), Brain Metastases and Treatment (7 papers), Lung Cancer Research Studies (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Spine and Intervertebral Disc Pathology (5 papers), Cancer Diagnosis and Treatment (4 papers), Reconstructive Surgery and Microvascular Techniques (4 papers) and Surgical site infection prevention (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.0k citations), Oncology (1.4k citations), Rheumatology (709 citations), Surgery (859 citations) and Cardiology and Cardiovascular Medicine (343 citations). Pierre Chabot has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Aileen M. Davis, Jay S. Wunder, Rita A. Kandel, Brian O’Sullivan, Joseph L. Pater, Charles Catton, Anna Sadura, Karen Goddard, Robert S. Bell and Benny Zee. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Journal of Neuro-Oncology and JAMA Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact